- Home
- PHVS vs AMSF Comparison
PHVS vs AMSF Comparison
Compare PHVS & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- AMSF
- Stock Information
- Founded
- PHVS 2015
- AMSF 1985
- Country
- PHVS Switzerland
- AMSF United States
- Employees
- PHVS N/A
- AMSF N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- PHVS Health Care
- AMSF Finance
- Exchange
- PHVS Nasdaq
- AMSF Nasdaq
- Market Cap
- PHVS 909.5M
- AMSF 918.6M
- IPO Year
- PHVS 2021
- AMSF 2005
- Fundamental
- Price
- PHVS $16.49
- AMSF $47.63
- Analyst Decision
- PHVS Strong Buy
- AMSF Buy
- Analyst Count
- PHVS 5
- AMSF 2
- Target Price
- PHVS $39.20
- AMSF $59.50
- AVG Volume (30 Days)
- PHVS 59.6K
- AMSF 77.1K
- Earning Date
- PHVS 05-13-2025
- AMSF 07-28-2025
- Dividend Yield
- PHVS N/A
- AMSF 9.49%
- EPS Growth
- PHVS N/A
- AMSF N/A
- EPS
- PHVS N/A
- AMSF 2.48
- Revenue
- PHVS N/A
- AMSF $301,216,000.00
- Revenue This Year
- PHVS N/A
- AMSF $1.69
- Revenue Next Year
- PHVS N/A
- AMSF $6.54
- P/E Ratio
- PHVS N/A
- AMSF $19.21
- Revenue Growth
- PHVS N/A
- AMSF N/A
- 52 Week Low
- PHVS $11.51
- AMSF $41.97
- 52 Week High
- PHVS $25.50
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- PHVS 51.83
- AMSF 50.38
- Support Level
- PHVS $15.46
- AMSF $45.80
- Resistance Level
- PHVS $16.99
- AMSF $48.54
- Average True Range (ATR)
- PHVS 1.04
- AMSF 0.97
- MACD
- PHVS -0.08
- AMSF 0.16
- Stochastic Oscillator
- PHVS 71.48
- AMSF 66.79
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums.